Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with ALK-Positive Non-Small-Cell Lung Cancer

Thumbnail Image

Files

Systemic Inflammatory Markers as a Predictors of Response to Crizotinib in Patients with.pdf (348.99 KB)

Date

2019-01-01

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

https://hdl.handle.net/11443/2581
 http://dx.doi.org/10.1016/j.jtho.2019.08.1407

Collections

WOS

Endorsement

Review

Supplemented By

Referenced By